TheEdgeResearch
Home / Stocks / LCI

Lannett Company, Inc. (LCI)

NYSE Healthcare Drug Manufacturers - Specialty & Generic
$0.69 ▲ +0.00%
Market Cap
$7.4M
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
0.95
52-Wk Range
0.0111-3.72
CEO
Timothy C. Crew
Country
US
Currency
USD

Lannett Company, Inc. operates as a U.S.-based pharmaceutical firm dedicated to the comprehensive process of developing, manufacturing, packaging, commercializing, and distributing generic versions of established brand-name drugs. Its extensive product portfolio encompasses a wide array of dosage forms, including solid oral, extended-release, topical, liquid, nasal, ophthalmic, injectable, patch, foam, buccal, sublingual, and suspension preparations. These generic medications address a broad spectrum of therapeutic areas, such as cardiovascular health, central nervous system disorders, endocri…

Open full interactive analysis & DCF →